Clinical Trial Update: Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating immunotherapy in patients with resected liver metastases from colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Duke Cancer Institute | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 1, Phase 2 | Status: COMPLETED